Digital health companies soared in popularity—and value—during the pandemic in 2020. The need for remote patient monitoring, telehealth visits and stronger revenue cycle management surged for providers. Investors flocked to the sector, pushing up valuations while pressuring players to succeed. The healthcare landscape continues to shift for both investors and providers. We’ll discuss which segments of this diverse universe are thriving today, why, and what should investors be watching for in 2022?